Gilgamesh Pharmaceuticals Inc.
New York, NY
- UEI
- Q6NKZ88FJMT5
- CAGE
- 8JEX4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 113 University Pl #1019, New York, NY 10003, USA
- Website
- gilgameshpharmaceutical.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a safer and more effective ibogaine analog for the treatment of opioid use disorder | National Institute on Drug Abuse (NIH) | $35,029,970 |
Quick answers
Is Gilgamesh Pharmaceuticals Inc. registered in SAM.gov?
Yes. Gilgamesh Pharmaceuticals Inc.'s SAM.gov registration is active through June 7, 2027.
What is Gilgamesh Pharmaceuticals Inc.'s most recent federal award?
Gilgamesh Pharmaceuticals Inc.'s most recent federal grant award is Development of a safer and more effective ibogaine analog for the treatment of opioid use disorder (UG3DA060053), from National Institute on Drug Abuse (NIH), on March 1, 2024.
On GovTribe
See Gilgamesh Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors